Johnson & Johnson ordered to pay $417 million in trial over talc cancer risks
Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company`s talc-based products like Johnson`s Baby Powder for feminine hygiene.
The Los Angeles Superior Court jury`s verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of talc-based products.
The verdict was confirmed by a spokeswoman for Echeverria`s lawyers. J&J said it will appeal.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.